[1].Carolin Fleischmann, Daniel O. Thomas–Rueddel:Hospital Incidence and Mortality Rates of Sepsis. MEDICINE. 2016; 113: 159–66.
[2].Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. doi: 10.1164/rccm.201504-0781oc.
[3].Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med 2003;348:1546–54.
[4].M. A. Puskarich, S. Trzeciak, N. I. Shapiro, A. C. Heffner, J.A. Kline, and A. E. Jones, “Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock,” Resuscitation, vol. 82, no. 10, pp. 1289–1293, 2011.
[5].M. D. Howell, M. Donnino, P. Clardy, D. Talmor, and N. I.Shapiro, “Occult hypoperfusion and mortality in patients with suspected infection,” Intensive Care Medicine, vol. 33, no. 11, pp.1892–1899, 2007.
[6].W.-Y. Kim, Y.-J. Lee, S. Yeon Lim et al., “Clinical characteristics and prognosis of pneumonia and sepsis: Multicenter Study,” Minerva Anestesiologica, vol. 79, no. 12, pp. 1356–1365, 2013.
[7].Florian B Mayr, Sachin Yende, and Derek C Angus. Epidemiology of severe sepsis. Virulence. 2014 Jan 1; 5(1): 4–11.
[8].Yang J, Li YJ, Liu QQ, Li L, Feng AZ, Wang TY, Zheng S, Xu AD and Lyu J. Brief introduction of medical database and data mining technology in big data era. Journal of Evidence-Based Medicine 2020, 13: 57–69. Medline
[9].Andrew Rhodes,Laura E. Evans, Waleed Alhazzani,Mitchell M. Levy and Massimo Antonelli,Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.Critical Care Medicine. 2017; 3:00–00. DOI: 10.1097/CCM.0000000000002255.
[10].Seymour CW, Liu VX, Iwashyna TJ, et al: Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:762–774
[11].Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data 2016;3:160035.
[12].Le Gall JR, Lemeshow S, Saulnier F. A New Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–63.
[13].Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–72.
[14].Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD). Ann Intern Med. 2015;162:735–6.
[15].Prescott HC, Langa KM, Liu V, Escobar GJ, Iwashyna TJ. Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;190(1):62–9.
[16].Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003 ; 101 : 3765–77 . doi:10.1182/blood-2002-06-1887 . pmid:12543869 .
[17].Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012 ; 122 : 2731–40 .
[18].Zhiqiang Liu, Zibo Meng, Yongfeng Li, Jingyuan Zhao, Shihong Wu, Shanmiao Gou and Heshui Wu. Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.(2019) 27:51.
[19].Ignacio Martin‑Loeches, Maria Consuelo Guia, Maria Sole Vallecoccia, David Suarez. Risk factors for mortality in elderly and very elderly critically ill patients with sepsis:a prospective, observational, multicenter cohort study. Ann. Intensive Care. (2019) 9:26.
[20].Yanfei Shen, Yangfang Lou and Shiping Zhu. Hyperthermia is a predictor of high mortality in patients with sepsis. Critical Care (2020) 24:543.
[21].Ryosuke Takegawa , Daijiro Kabata , Kentaro Shimizu , Saya Hisano , Hiroshi Ogura a,Ayumi Shintani , Takeshi Shimazu. Serum albumin as a risk factor for death in patients with prolonged sepsis: An observational study. Journal of Critical Care .51 (2019) 139–144.
[22].S. Dietz, C. Lautenschläger, U. Müller-Werdan, G. Pilz,P. Fraunberger, M. Päsler,H. Ebelt,A. K. Walli, K. Werdan, S. Nuding. Serum IgG levels and mortality in patients with severe sepsis and septic shock. Med Klin Intensivmed Notfmed. DOI 10.1007/s00063-016-0220-6.
[23].Jean‑Louis Vincent , Nathan D. Nielsen, Nathan I. Shapiro, Margaret E. Gerbasi. Mean arterial pressure and mortality in patients with distributive shock:a retrospective analysis of the MIMIC-III database. Ann. Intensive Care (2018) 8:107.
[24].Song JY, Park DW, Moon SW, et al. Validation of APACHE II and SAPS II scales at the intensive care unit along with assessment of SOFA scale at the admission as an isolated risk of death predictor. Anaesthesiol Intensive Ther. 2019b;51(2):107–11.
[25].Min Ho Seo, Minhong Choa, Je Sung You, et al. Tachypnea Predict 28-Day Mortality in Severe Sepsis and Septic Shock Patients in the Emergency Department. Yonsei Med J 2016 Nov;57(6):1361–1369.
[26].Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest. 2003; 124(3):1016–20.
[27].Dhainaut JF, Marin N, Mignon A, Vinsonneau C. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med. 2001; 29(7 Suppl):S42–7.
[28].Siore AM, Parker RE, Stecenko AA, Cuppels C, McKean M, Christman BW, et al. Endotoxininduced acute lung injury requires interaction with the liver. Am J Physiol Lung Cell Mol Physiol. 2005; 289(5):L769–76.
[29].von Baehr V, Docke WD, Plauth M, Liebenthal C, Kupferling S, Lochs H, Baumgarten R, Volk HD. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut. 2000; 47(2):281–7.
[30].Poutsiaka DD, Davidson LE, Kahn KL, Bates DW, Snydman DR, Hibberd PL. Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis. Scand J Infect Dis 2009;41:469–479.
[31].Tolsma V, Schwebel C, Azoulay E, Darmon M, Souweine B, Vesin A, et al. Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile. Chest 2014;146:1205–1213.
[32].Gajewski TF, Schreiber H & Fu YX Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14, 1014–1022 (2013).
[33].J M Michot , C Bigenwald , S Champiat et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer. 2016 Feb;54:139–148.
[34].Jie Ni, MD, Hongye Wang, MS, Yue Li, MS ,et al. Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis. Medicine (2019) 98:46.